Bio-Techne (FRA:TE1) Accumulated Depreciation : €-232 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Bio-Techne Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Bio-Techne's quarterly accumulated depreciation declined from Sep. 2023 (€-226 Mil) to Dec. 2023 (€-225 Mil) but then increased from Dec. 2023 (€-225 Mil) to Mar. 2024 (€-232 Mil).

Bio-Techne's annual accumulated depreciation increased from Jun. 2021 (€-158 Mil) to Jun. 2022 (€-200 Mil) and increased from Jun. 2022 (€-200 Mil) to Jun. 2023 (€-216 Mil).

Bio-Techne Accumulated Depreciation Historical Data

The historical data trend for Bio-Techne's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Accumulated Depreciation Chart

Bio-Techne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accumulated Depreciation

Get a 7-Day Free Trial

-134.77

-150.80

-157.58

-200.01

-215.72

Bio-Techne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-215.22	-215.72	-225.80	-224.86	-231.75

Bio-Techne Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Bio-Techne Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne (FRA:TE1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (FRA:TE1) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

TECH:USA T1CH34:Brazil

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne (FRA:TE1) Headlines

No Headlines